How a Global Biologics CDMO Drove End-to-End Engagement Using Precision ABM with BambooBox
How a Global Biologics CDMO Drove End-to-End Engagement Using Precision ABM with BambooBox
In a $24B+ market where most CDMOs sound alike, this global Biologics player stopped chasing accounts and started winning them before the RFP even began.
The Challenges
Most Biologics CDMOs operate in a market where scientific and regulatory credentials look identical on paper. Our client, a global Biologics CDMO targeting large pharma, mid-sized biopharma, and emerging biotech had the capability. What they lacked was a way to get in front of the right accounts early, before a shortlist was formed.
The core challenges:
- No visibility into which accounts were actively exploring outsourcing or scale-up
- Complex, cross-functional buying committees with no unified engagement view
- Long decision cycles where meaningful engagement only started after vendors were shortlisted
- Difficulty standing out in a crowded global CDMO landscape
The Solution
BambooBox built a precision ABM engine combining intent intelligence, creative differentiation, and multi-channel orchestration, designed to engage priority biopharma and biotech accounts across the US and Europe at scale.
Intent-Led Account Prioritisation
Third-party intent signals across biologics topics, including monoclonal antibodies, recombinant proteins, manufacturing scale-up, were used to build cohorts of in-market accounts and activate hyper-targeted campaigns before competitors entered the picture.
A Full-Funnel, Multi-Channel Campaign Architecture
A three-stage funnel (Awareness → Consideration → Conversion) ran across LinkedIn and Google, with stage-specific messaging for each buyer type and persona. Retargeting kept the client visible throughout long evaluation cycles.
Creative That Cut Through Category Noise
The Art of Science, a distinctive visual identity combining microscopy imagery, molecular structures, and watercolour themes, helped the client stand apart instantly across digital touchpoints and improve recall in a saturated market.
Thought Leadership Mapped to Every Buyer Segment
Content was built around outcomes, not just capabilities, addressing the distinct priorities of emerging biotech, mid-sized pharma, and large pharma across R&D, CMC, manufacturing, and leadership personas.
Results
134%
Growth in accounts moving from TOFU to MOFU over a 3-month period.
63%
Reduction in cost-per-conversion, with CTR consistently above 3%
70+
Accounts converted into BOFU-stage (Potential Opportunities) and qualified as MQLs through ongoing multi-channel engagement.
20+
Accounts advanced within BOFU, progressing from Potential Opportunities to Active Opportunities in the course of the campaign across the different motions of discovery and development
1,700+
Accounts from the TAM engaged across LinkedIn campaigns
Expanded buying group visibility, with multi-stakeholder engagement across scientific, manufacturing, and leadership roles per account
Ready to See What This Looks Like for Your Business?
In biologics outsourcing and pharma manufacturing, pipeline is rarely built at the moment of inquiry. It is built in the months before a buyer ever fills out a form or sends an RFP. The CDMOs and pharma manufacturers that win global customers aren’t necessarily the ones with the best capabilities. They’re the ones who showed up early, stayed visible, and earned trust before the evaluation even began.
This case study is a detailed look at how one global Biologics CDMO built exactly that kind of engine, from intent-led account prioritisation to multi-channel campaign execution to buying group engagement across the US and Europe. The full strategy, creative approach, channel breakdown, and results are all inside.
If you’re a pharma manufacturer, CDMO, or API exporter trying to find global buyers in the US, Europe, or APAC, and your marketing team is small, under pressure, and tired of approaches that are not working, BambooBox works with pharma and life sciences companies to build pipeline-focused ABM programs designed for exactly this challenge. We’d love to understand your situation and show you what this looks like for your market.